Ronald E. Esser

760 total citations
14 papers, 634 citations indexed

About

Ronald E. Esser is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ronald E. Esser has authored 14 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Ronald E. Esser's work include Immune Response and Inflammation (3 papers), Inflammatory mediators and NSAID effects (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). Ronald E. Esser is often cited by papers focused on Immune Response and Inflammation (3 papers), Inflammatory mediators and NSAID effects (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). Ronald E. Esser collaborates with scholars based in United States, Switzerland and France. Ronald E. Esser's co-authors include John H. Schwab, William J. Cromartie, Stephen A. Stimpson, Lynnetta M. Watts, Larry P. Thornburg, James T. Palmer, Mark D. Murphey, Kathleen Frondorf, Jamil W. Talhouk and Robert E. Smith and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Infection and Immunity.

In The Last Decade

Ronald E. Esser

14 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ronald E. Esser United States	13	221	152	125	109	105	14	634
J. Schnyder Switzerland	9	169 0.8×	69 0.5×	161 1.3×	86 0.8×	56 0.5×	17	576
Matthew J. Peirce United Kingdom	13	367 1.7×	39 0.3×	178 1.4×	72 0.7×	61 0.6×	31	718
J C Salomon France	18	387 1.8×	118 0.8×	388 3.1×	38 0.3×	151 1.4×	45	1.0k
Chieh‐Shan Wu Taiwan	17	254 1.1×	58 0.4×	122 1.0×	32 0.3×	68 0.6×	48	884
Joachim Saas Germany	14	361 1.6×	148 1.0×	56 0.4×	426 3.9×	91 0.9×	15	837
Susan E. Sweeney United States	13	295 1.3×	43 0.3×	269 2.2×	261 2.4×	188 1.8×	19	839
Eberhard Buchner Germany	9	175 0.8×	87 0.6×	117 0.9×	126 1.2×	112 1.1×	15	500
Jesús Gardeazábal Spain	18	199 0.9×	58 0.4×	194 1.6×	87 0.8×	144 1.4×	60	845
Wilhelm Brenner Austria	18	161 0.7×	36 0.2×	313 2.5×	46 0.4×	53 0.5×	25	918
Xiaoming Wu China	15	303 1.4×	41 0.3×	101 0.8×	88 0.8×	135 1.3×	46	709

Countries citing papers authored by Ronald E. Esser

Since Specialization

Citations

This map shows the geographic impact of Ronald E. Esser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald E. Esser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald E. Esser more than expected).

Fields of papers citing papers by Ronald E. Esser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald E. Esser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald E. Esser. The network helps show where Ronald E. Esser may publish in the future.

Co-authorship network of co-authors of Ronald E. Esser

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald E. Esser. A scholar is included among the top collaborators of Ronald E. Esser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald E. Esser. Ronald E. Esser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

King, Jonathan N., Janet Dawson, Ronald E. Esser, et al.. (2009). Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase‐2. Journal of Veterinary Pharmacology and Therapeutics. 32(1). 1–17. 55 indexed citations

Esser, Ronald E., et al.. (2005). Pharmacodynamic behaviour of the selective cyclooxygenase-2 inhibitor lumiracoxib in the lipopolysaccharide-stimulated rat air pouch model. European Journal of Pharmaceutical Sciences. 25(1). 25–30. 11 indexed citations

Révész, Láśzló, Birgit Bollbuck, Thomas Buhl, et al.. (2005). Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritis. Bioorganic & Medicinal Chemistry Letters. 15(23). 5160–5164. 24 indexed citations

Esser, Ronald E., Carol Berry, Zhengming Du, et al.. (2005). Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase‐2. British Journal of Pharmacology. 144(4). 538–550. 100 indexed citations

Esser, Ronald E., et al.. (1995). Measurement of radiographic changes in adjuvant-induced arthritis in rats by quantitative image analysis. Arthritis & Rheumatism. 38(1). 129–138. 24 indexed citations

Esser, Ronald E., Mark D. Murphey, Lynnetta M. Watts, et al.. (1994). Cysteine Proteinase Inhibitors Decrease Articular Cartilage and Bone Destruction in Chronic Inflammatory Arthritis. Arthritis & Rheumatism. 37(2). 236–247. 107 indexed citations

Frondorf, Kathleen, et al.. (1993). Immunosuppression mediated by an inhibitor of S-adenosyl-L-homocysteine hydrolase. Prevention and treatment of collagen-induced arthritis.. The Journal of Immunology. 151(1). 526–534. 50 indexed citations

Esser, Ronald E., et al.. (1993). The effects of fluoromethyl ketone inhibitors of cathepsin B on adjuvant induced arthritis.. PubMed. 20(7). 1176–83. 36 indexed citations

Ahmed, Nahed K., et al.. (1992). Peptidyl fluoromethyl ketones as inhibitors of cathepsin B. Biochemical Pharmacology. 44(6). 1201–1207. 46 indexed citations

10.

Stimpson, Stephen A., et al.. (1987). Lipopolysaccharide induces recurrence of arthritis in rat joints previously injured by peptidoglycan-polysaccharide.. The Journal of Experimental Medicine. 165(6). 1688–1702. 47 indexed citations

11.

Stimpson, Stephen A., Ronald E. Esser, William J. Cromartie, & John H. Schwab. (1986). Comparison of in vivo degradation of 125I-labeled peptidoglycan-polysaccharide fragments from group A and group D streptococci. Infection and Immunity. 52(2). 390–396. 28 indexed citations

12.

Esser, Ronald E., S K Anderle, Chellu S. Chetty, et al.. (1986). Comparison of inflammatory reactions induced by intraarticular injection of bacterial cell wall polymers.. PubMed. 122(2). 323–34. 26 indexed citations

13.

Janusz, Michael J., Ronald E. Esser, & John H. Schwab. (1986). In vivo degradation of bacterial cell wall by the muralytic enzyme mutanolysin. Infection and Immunity. 52(2). 459–467. 18 indexed citations

14.

Esser, Ronald E., Stephen A. Stimpson, William J. Cromartie, & John H. Schwab. (1985). Reactivation of streptococcal cell wall‐induced arthritis by homologous and heterologous cell wall polymers. Arthritis & Rheumatism. 28(12). 1402–1411. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact